Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Otto Metzger

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
The New England Journal of Medicine|April 29, 2026
Palbociclib for HR-Positive, HER2-Positive Breast Cancer. ReplyOtto Metzger
Dermatology Research and Practice|January 5, 2012
Targeting the Cellular Signaling: BRAF Inhibition and Beyond for the Treatment of Metastatic Malignant MelanomaFelipe Ades, Otto Metzger-Filho
Cancer Cell|October 20, 2012
SnapShot: breast cancerKornelia Polyak, Otto Metzger Filho
Therapeutic Advances in Medical Oncology|August 3, 2016
Differences between invasive lobular and invasive ductal carcinoma of the breast: results and therapeutic implicationsRomualdo Barroso-Sousa, Otto Metzger-Filho
Journal of the National Cancer Institute. Monographs|November 2, 2011
Neoadjuvant chemotherapy and targeted therapies: a promising strategyOtto Metzger-Filho, Evandro de Azambuja
Nature Reviews. Clinical Oncology|August 9, 2017
Breast cancer: T-DM1 - an important agent in the history of breast cancer managementOtto Metzger-Filho, Eric P Winer
Current Opinion in Oncology|May 21, 2010
First-line systemic treatment of ovarian cancer: a critical review of available evidence and expectations for future directionsOtto Metzger-Filho, Camilo Moulin, Veronique D'Hondt
Expert Opinion on Investigational Drugs|April 9, 2010
Management of metastatic HER2-positive breast cancer progression after adjuvant trastuzumab therapy - current evidence and future trendsOtto Metzger-Filho, Tushar Vora, Ahmad Awada
Current Clinical Pharmacology|April 22, 2010
Molecular targeted therapy in prevalent tumors: learning from the past and future perspectivesOtto Metzger-Filho, Camilo Moulin, Ahmad Awada
Future Oncology (London, England)|August 12, 2009
Changing the clinical picture of challenging tumors: tales becoming reality?Camilo Moulin, Otto Metzger-Filho, Ahmad Awada
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
The New England Journal of Medicine|April 29, 2026
Palbociclib for HR-Positive, HER2-Positive Breast Cancer. ReplyOtto Metzger
Dermatology Research and Practice|January 5, 2012
Targeting the Cellular Signaling: BRAF Inhibition and Beyond for the Treatment of Metastatic Malignant MelanomaFelipe Ades, Otto Metzger-Filho
Cancer Cell|October 20, 2012
SnapShot: breast cancerKornelia Polyak, Otto Metzger Filho
Therapeutic Advances in Medical Oncology|August 3, 2016
Differences between invasive lobular and invasive ductal carcinoma of the breast: results and therapeutic implicationsRomualdo Barroso-Sousa, Otto Metzger-Filho
Journal of the National Cancer Institute. Monographs|November 2, 2011
Neoadjuvant chemotherapy and targeted therapies: a promising strategyOtto Metzger-Filho, Evandro de Azambuja
Nature Reviews. Clinical Oncology|August 9, 2017
Breast cancer: T-DM1 - an important agent in the history of breast cancer managementOtto Metzger-Filho, Eric P Winer
Current Opinion in Oncology|May 21, 2010
First-line systemic treatment of ovarian cancer: a critical review of available evidence and expectations for future directionsOtto Metzger-Filho, Camilo Moulin, Veronique D'Hondt
Expert Opinion on Investigational Drugs|April 9, 2010
Management of metastatic HER2-positive breast cancer progression after adjuvant trastuzumab therapy - current evidence and future trendsOtto Metzger-Filho, Tushar Vora, Ahmad Awada
Current Clinical Pharmacology|April 22, 2010
Molecular targeted therapy in prevalent tumors: learning from the past and future perspectivesOtto Metzger-Filho, Camilo Moulin, Ahmad Awada
Future Oncology (London, England)|August 12, 2009
Changing the clinical picture of challenging tumors: tales becoming reality?Camilo Moulin, Otto Metzger-Filho, Ahmad Awada
Pageof 10